Juan C Hernandez-Prera
Overview
Explore the profile of Juan C Hernandez-Prera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mansour M, Hernandez-Prera J
Head Neck Pathol
. 2025 Mar;
19(1):35.
PMID: 40088323
Sinus content specimens from patients with chronic rhinosinusitis (CRS) are commonly encountered by surgical pathologists across various practice settings. The inflammatory cellular component of CRS often includes eosinophil-rich inflammation, and...
2.
Hart S, Hang J, Chernock R, Mikula M, Rooper L, Amin S, et al.
Am J Surg Pathol
. 2024 Dec;
49(2):130-137.
PMID: 39719672
DEK :: AFF2 fusion nonkeratinizing squamous cell carcinoma (NKSCC) is an emerging entity in the sinonasal tract, temporal bone, and skull base. However, the clinical behavior of these tumors has...
3.
Tasoulas J, Schrank T, Bharambe H, Mehta J, Johnson S, Divaris K, et al.
Sci Rep
. 2024 Jul;
14(1):15821.
PMID: 38982149
Adenoid cystic carcinoma (AdCC) is a slow-growing salivary gland malignancy that relapses frequently. AdCCs of the submandibular gland exhibit unique differences in prognosis and treatment response to adjuvant radiotherapy compared...
4.
Hernandez-Prera J, Wenig B
Endocr Pathol
. 2024 Jun;
35(3):167-184.
PMID: 38888731
The classification of thyroid nodules, particularly those with a follicular growth pattern, has significantly evolved. These tumors, enriched with RAS or RAS-like mutations, remain challenging for pathologists due to variables...
5.
Hernandez-Prera J
Clin Lab Med
. 2024 May;
44(2):305-324.
PMID: 38821646
The molecular signatures of many thyroid tumors have been uncovered. These discoveries have translated into clinical practice and are changing diagnostic and tumor classification paradigms. Here, the findings of recent...
6.
Furlan K, Saeed-Vafa D, Mathew T, Saller J, Tabbara S, Boyle T, et al.
Head Neck Pathol
. 2024 Feb;
18(1):11.
PMID: 38393464
Background: Metastatic carcinoma of unknown primary origin to the head and neck lymph nodes (HNCUP) engenders unique diagnostic considerations. In many cases, the detection of a high-risk human papillomavirus (HR-HPV)...
7.
Xie M, Chaudhary R, Slebos R, Lee K, Song F, Poole M, et al.
Mol Carcinog
. 2023 Sep;
63(1):120-135.
PMID: 37750589
Head and neck squamous cell carcinomas (HNSCC) remain a poorly understood disease clinically and immunologically. HPV is a known risk factor of HNSCC associated with better outcome, whereas HPV-negative HNSCC...
8.
Chaudhary R, Slebos R, Noel L, Song F, Poole M, Hoening D, et al.
Cancer Res Commun
. 2023 Jun;
3(5):896-907.
PMID: 37377902
Significance: While the hypoxic and immunosuppressive TME of HNSCC has been well described, comprehensive evaluation of the immune cell components and signaling pathways contributing to immunotherapy resistance has been poorly...
9.
Patel K, Padhya T, Huang J, Hernandez-Prera J, Li T, Chung C, et al.
Mol Carcinog
. 2023 Jan;
62(4):493-502.
PMID: 36636912
Head and neck squamous cell carcinoma (HNSCC), a highly heterogeneous disease that involves multiple anatomic sites, is a leading cause of cancer-related mortality worldwide. Although the utility of noninvasive biomarkers...
10.
Chung C, Li J, Steuer C, Bhateja P, Johnson M, Masannat J, et al.
Clin Cancer Res
. 2022 Mar;
28(11):2329-2338.
PMID: 35344035
Purpose: A phase II multi-institutional clinical trial was conducted to determine overall survival (OS) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) treated with...